New drug tested for scarred lungs
NCT ID NCT04540770
Summary
This was the first human study of an experimental drug called HuL001 for idiopathic pulmonary fibrosis, a serious lung scarring disease. Researchers tested the drug's safety and how it moves through the body in 24 people—first in healthy volunteers, then in patients with the condition. The main goal was to see what side effects occurred and determine safe dosage levels for future testing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mackay Memorial Hospital
New Taipei City, Taiwan
-
National Taiwan University Hospital
Taipei, Taiwan
Conditions
Explore the condition pages connected to this study.